CLINICAL_TRIALS
trial_result
· 2023-11-29
Clinical Trial Update: Complement Regulation to Undo Systemic Harm in Preeclampsia [Phase 2]
Summary
Phase 2 trial in preeclampsia investigating complement regulation to mitigate systemic harm; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Cedars-Sinai Medical Center | Conditions: Preeclampsia, Severe Preeclampsia | Phase 2 | Status: TERMINATED | Results posted: 2023-11-29